Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Completed · Phase 3

Conditions studied: Parkinson Disease

In brief

An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

Key facts

Study ID

NCT02542696

Run by

Sumitomo Pharma America, Inc.

People needed

496

Starts

2015-08-31

Expected to finish

2022-11-08

Last updated by the study team

2023-11-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Muhammed Ali Parkinson and Movement Disorder Center/Barrow Neurological Institute — Phoenix, Arizona, United States
• Movement Disorders Center of Arizona — Scottsdale, Arizona, United States
• Clinical Trials, Inc. — Little Rock, Arkansas, United States
• The Parkinson's and Movement Disorder Institute — Fountain Valley, California, United States
• UC Irvine Health Gottschalk Medical Plaza — Irvine, California, United States
• Keck Medical Center at USC — Los Angeles, California, United States
• University of Colorado School of Medicine — Aurora, Colorado, United States
• MedStar Georgetown University Hospital — Washington D.C., District of Columbia, United States
• Parkinsons Disease and Movement Disorders Center — Boca Raton, Florida, United States
• University of Miami, Miller School of Medicine — Miami, Florida, United States
• Parkinson's Disease Treatment Center of Southwest Florida — Port Charlotte, Florida, United States
• Suncoast Neuroscience Associates Inc. — St. Petersburg, Florida, United States
• USF Parkinson's Disease and Movement Disorder Center — Tampa, Florida, United States
• Emory University Department of Neurology — Atlanta, Georgia, United States
• GRU Movement Disorders — Augusta, Georgia, United States
• Northwestern University — Chicago, Illinois, United States
• Rush University Medical Center — Chicago, Illinois, United States
• NorthShore Neurological Institute B043D — Glenview, Illinois, United States
• Central DuPage Hospital - Neurodegenerative Clinic - Movement Disorders Center — Winfield, Illinois, United States
• University of Iowa Dept. of Neurology — Iowa City, Iowa, United States
• Kansas University Medical Center-Department of Neurology — Kansas City, Kansas, United States
• University of Kentucky — Lexington, Kentucky, United States
• University of Maryland — Baltimore, Maryland, United States
• Johns Hopkins University — Baltimore, Maryland, United States
• University of Alabama Birmingham — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.